Company Overview - Elutia Inc. is a pioneer in drug-eluting biomatrix products aimed at improving compatibility between medical devices and patients [3] - The company's mission is to humanize medicine, allowing patients to thrive without compromise, particularly in the context of a growing population in need of implantable technologies [3] Upcoming Presentation - Dr. Randy Mills, President and CEO of Elutia, will present at the Emerging Growth Conference on July 18, 2024, at 12:35 p.m. ET [1] - Following the presentation, Elutia management will engage in one-on-one investor meetings, with institutional investors encouraged to schedule meetings via email [2] Conference Details - The Emerging Growth Conference serves as a platform for public companies to present new products, services, and major announcements to the investment community efficiently [4] - The conference targets a wide range of growth sectors and attracts a diverse audience, including individual and institutional investors, investment advisors, and analysts [5]
Elutia to Present at the Emerging Growth Conference on Thursday, July 18